Weird is becoming Askmi. Your account, choices, circles, and history stay exactly where they are.

Web Content

Add something from the web Paste a URL and Weird will route it into the right native section.
Back to Web Content
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol | FDA
Web Content

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol | FDA

Interesting · www.fda.gov · generic

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemi

TypeWeb Page
Domainwww.fda.gov
Providergeneric
Recommend it?
Open in Weird Source

Taste signal

CommunityNo votes yet
Total ratings0
Your signalNot rated

No high-context match details yet. As more Taste Twins rate this, this section will show who aligns with your taste here.

Useful info

We have the community taste signal, but richer practical fields for this item are not populated yet.

Open source

More like this

Anthropic says these topics are too dangerous to let its Fable 5 model talk about - Ars TechnicaInteresting thousands of drones reimagine taipei’s skyline as an urban canvasInteresting 8 Songs You Didn't Know Were Written By Willie NelsonInteresting Your Cat Can Bring Home More Disease Than You Think. Here's What to Do. : ScienceAlertInteresting They have floating gas stations in the middle of the water to fill up your boats tank.Interesting Oil droplets remodel themselves, swallow their surroundings like living cellsInteresting

Tips and insights

Create a profile to add tips or personal takes.
Sign up Log in
No tips yet. Add the first useful note for this item.